These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 32819504)

  • 1. Solid phase extraction-based separation of the nuclear isomers
    Bhardwaj R; Wolterbeek HT; Denkova AG; Serra-Crespo P
    Appl Radiat Isot; 2020 Oct; 164():109264. PubMed ID: 32819504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radionuclide generator-based production of therapeutic 
    Bhardwaj R; Wolterbeek HT; Denkova AG; Serra-Crespo P
    EJNMMI Radiopharm Chem; 2019 Jul; 4(1):13. PubMed ID: 31659496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modelling of the
    Bhardwaj R; Wolterbeek HT; Denkova AG; Serra-Crespo P
    Appl Radiat Isot; 2020 Dec; 166():109261. PubMed ID: 32961525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Large-scale production of lutetium-177m for the
    Bhardwaj R; Ponsard B; Sarilar M; Wolterbeek B; Denkova A; Serra-Crespo P
    Appl Radiat Isot; 2020 Feb; 156():108986. PubMed ID: 31786419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Separation of nuclear isomers for cancer therapeutic radionuclides based on nuclear decay after-effects.
    Bhardwaj R; van der Meer A; Das SK; de Bruin M; Gascon J; Wolterbeek HT; Denkova AG; Serra-Crespo P
    Sci Rep; 2017 Mar; 7():44242. PubMed ID: 28287131
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of the
    Balzer M; Spiecker F; Bluemel S; Amthauer H; Brenner W; Spreckelmeyer S
    EJNMMI Radiopharm Chem; 2023 Nov; 8(1):37. PubMed ID: 37930495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Technical note: Quantifying radionuclide residues in hospital wastewater: A case study on [
    Kupitz D; Einspänner E; Wissel H; Volk M; Hohn A; Kreissl MC; Grosser OS
    Med Phys; 2024 Jun; ():. PubMed ID: 38922963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Technical note: Assessment of radiation measurement devices for the detection of [
    Kupitz D; Einspänner E; Wissel H; Hohn A; Kreissl MC; Grosser OS
    Med Phys; 2023 Jan; 50(1):590-599. PubMed ID: 36208077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo evaluation of pretargeted 64Cu for tumor imaging and therapy.
    Lewis MR; Wang M; Axworthy DB; Theodore LJ; Mallet RW; Fritzberg AR; Welch MJ; Anderson CJ
    J Nucl Med; 2003 Aug; 44(8):1284-92. PubMed ID: 12902420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and biological evaluation of 111In-, 177Lu- and 90Y-labeled DOTA analogues conjugated to B72.3.
    Mohsin H; Fitzsimmons J; Shelton T; Hoffman TJ; Cutler CS; Lewis MR; Athey PS; Gulyas G; Kiefer GE; Frank RK; Simon J; Lever SZ; Jurisson SS
    Nucl Med Biol; 2007 Jul; 34(5):493-502. PubMed ID: 17591549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, Radiolabeling, and Characterization of Plasma Protein-Binding Ligands: Potential Tools for Modulation of the Pharmacokinetic Properties of (Radio)Pharmaceuticals.
    Müller C; Farkas R; Borgna F; Schmid RM; Benešová M; Schibli R
    Bioconjug Chem; 2017 Sep; 28(9):2372-2383. PubMed ID: 28898054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiochemical investigations of 177Lu-DOTA-8-Aoc-BBN[7-14]NH2: an in vitro/in vivo assessment of the targeting ability of this new radiopharmaceutical for PC-3 human prostate cancer cells.
    Smith CJ; Gali H; Sieckman GL; Hayes DL; Owen NK; Mazuru DG; Volkert WA; Hoffman TJ
    Nucl Med Biol; 2003 Feb; 30(2):101-9. PubMed ID: 12623108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Term Retention of 177Lu/177mLu-DOTATATE in Patients Investigated by γ-Spectrometry and γ-Camera Imaging.
    Gleisner KS; Brolin G; Sundlöv A; Mjekiqi E; Östlund K; Tennvall J; Larsson E
    J Nucl Med; 2015 Jul; 56(7):976-84. PubMed ID: 25999429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioimmunotherapy of a human lung cancer xenograft with monoclonal antibody RS7: evaluation of (177)Lu and comparison of its efficacy with that of (90)Y and residualizing (131)I.
    Stein R; Govindan SV; Chen S; Reed L; Richel H; Griffiths GL; Hansen HJ; Goldenberg DM
    J Nucl Med; 2001 Jun; 42(6):967-74. PubMed ID: 11390564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consequences of meta-stable (177m)Lu admixture in (177)Lu for patient dosimetry.
    Konijnenberg MW
    Curr Radiopharm; 2015; 8(2):145-9. PubMed ID: 25771362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Vivo Labeling of Plasma Proteins for Imaging of Enhanced Vascular Permeability in the Lungs.
    Schniering J; Borgna F; Siwowska K; Benešová M; Cohrs S; Hasler R; van der Meulen NP; Maurer B; Schibli R; Müller C
    Mol Pharm; 2018 Nov; 15(11):4995-5004. PubMed ID: 30265552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrocyclic complexes of scandium radionuclides as precursors for diagnostic and therapeutic radiopharmaceuticals.
    Majkowska-Pilip A; Bilewicz A
    J Inorg Biochem; 2011 Feb; 105(2):313-20. PubMed ID: 21194633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recovery of
    Kazakov AG; Ekatova TY; Babenya JS; Belyshev SS; Khankin VV; Kuznetsov AA; Vinokurov SE; Myasoedov BF
    Molecules; 2022 May; 27(10):. PubMed ID: 35630655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Panitumumab Modified with Metal-Chelating Polymers (MCP) Complexed to
    Aghevlian S; Lu Y; Winnik MA; Hedley DW; Reilly RM
    Mol Pharm; 2018 Mar; 15(3):1150-1159. PubMed ID: 29314858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and evaluation of novel bifunctional chelating agents based on 1,4,7,10-tetraazacyclododecane-N,N',N",N"'-tetraacetic acid for radiolabeling proteins.
    Chappell LL; Ma D; Milenic DE; Garmestani K; Venditto V; Beitzel MP; Brechbiel MW
    Nucl Med Biol; 2003 Aug; 30(6):581-95. PubMed ID: 12900284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.